Background: Wild-type huntingtin (HTT) interacts with synaptic proteins, yet its role in synaptic function is unclear. Results: HTT bidirectionally influences PSD-95 clustering in striatal spiny projection neurons. Conclusion: HTT plays a role in synaptic protein organization. Significance: HTT-reducing strategies are being tested as a treatment for Huntington disease. It is therefore critical to understand the role of HTT in cellular and synaptic function.
Huntington disease is associated with early alterations in corticostriatal synaptic function that precede cell death, and it is postulated that ameliorating such changes may delay clinical onset and/or prevent neurodegeneration. Although many of these synaptic alterations are thought to be attributable to a toxic gain of function of the mutant huntingtin protein, the role that nonpathogenic huntingtin (HTT) plays in synaptic function is relatively unexplored. Here, we compare the immunocytochemical localization of a major postsynaptic scaffolding protein, PSD-95, in striatal neurons from WT mice and mice overexpressing HTT with 18 glutamine repeats (YAC18, nonpathogenic). We found that HTT overexpression resulted in a palmitoylation-and BDNF-dependent increase in PSD-95 clustering at synaptic sites in striatal spiny projection neurons (SPNs) co-cultured with cortical neurons. Surprisingly, the latter effect was mediated presynaptically, as HTT overexpression in cortical neurons alone was sufficient to increase PSD-95 clustering in the postsynaptic SPNs. In contrast, antisense oligonucleotide knockdown of HTT in WT co-cultures resulted in a significant reduction of PSD-95 clustering in SPNs. Notably, despite these bidirectional changes in PSD-95 clustering, we did not observe an alteration in basal electrophysiological measures of AMPA and NMDA receptors. Thus, unlike in previous studies in the hippocampus, enhanced or decreased PSD-95 clustering alone was insufficient to drive AMPA or NMDA receptors into or out of SPN synapses. In all, our results demonstrate that nonpathogenic HTT can indeed influence synaptic protein localization and uncover a novel role of HTT in PSD-95 distribution.
Huntington disease (HD) 3 is caused by a CAG triplet repeat expansion in the gene encoding the huntingtin (HTT) protein. This mutation generates an N-terminal polyglutamine expansion within the HTT protein and results in a broad array of deficits in cellular and synaptic function, particularly within the GABAergic spiny projection neurons (SPNs) of the striatum (1) . Many of these deficits precede cell death and overt motor symptoms, suggesting that the prevention of these early changes may ameliorate disease progression. Although much of the cellular toxicity in HD has been generally attributed to a gain of function of the polyglutamine-expanded mutant HTT (mHTT), little is known regarding the role of non-expanded wild-type HTT (wtHTT) in synaptic function.
Over the past 15-20 years, it has become clear that wtHTT exerts a prosurvival function. Homozygous knock-out of wtHTT is embryonic lethal (2) (3) (4) , and overexpression of wtHTT can protect neurons from excitotoxic insult and other apoptotic stimuli (5, 6) as well as reduce the toxicity associated with mHTT (7) . However, the precise biological role of wtHTT has been difficult to establish due to its ubiquitous expression both within and outside the central nervous system, its diffuse intracellular localization, and its wide variety of interacting partners.
wtHTT interacts strongly with microtubules and vesicular membrane proteins (8, 9) , leading to the suggestion that wtHTT can facilitate global intracellular vesicular trafficking via these interactions (10) . A recent study identified over 700 putative proteins that form complexes with HTT. This interactome revealed networks of proteins involved in diverse biological functions, providing further support for a wide-ranging functional role of wtHTT. Of interest to the present study is the finding that some of the key HTT interactors include proteins involved in neurotransmitter transport as well as pre-and postsynaptic organization and function, thereby suggesting a role for wtHTT in synaptic signaling (11) .
The membrane-associated guanylate kinases are critical postsynaptic scaffolding proteins. PSD-95, the prototypical membrane-associated guanylate kinase, is highly enriched at excitatory synapse postsynaptic densities and functions to anchor and organize glutamate receptors and various signaling molecules at the postsynapse (12, 13) . Interestingly, this scaffold represents a key "hub" in the HTT interactome (11) , and the presence of a pathological polyglutamine expansion in HTT weakens this interaction (14) and mislocalizes PSD-95 to extrasynaptic sites (15) . As PSD-95 binds directly to NMDA receptors (NMDARs) (16) and indirectly to AMPA receptors (AMPARs) via transmembrane AMPAR regulatory proteins (17) , HTT effects on PSD-95 localization may critically influence AMPAR and/or NMDAR signaling. Indeed, our laboratory has recently demonstrated an early increase in cell deathassociated (18) extrasynaptic NMDARs in the YAC128 mouse model of HD (19) . In the present study, we investigated the role of wtHTT in the subcellular distribution of PSD-95.
EXPERIMENTAL PROCEDURES
Animals were housed and maintained according to the Canadian Council on Animal Care, and all procedures were approved by the University of British Columbia Committee on Animal Care. All data were obtained from WT FVB/N controls and YAC18 mice (line 212), which overexpress full-length wtHTT (human) with a polyglutamine length of 18 on an FVB/N background (20) . All data are presented as means Ϯ S.E.
Corticostriatal Co-cultures and Transfections-Neuronal culture preparation and maintenance were similar to those described previously (21, 22) . Briefly, striatal and cortical tissues were dissected from Day 17-18 WT FVB/N or YAC18 embryos in ice-cold Hanks' balanced salt solution (Invitrogen), digested in trypsin, and further dissociated in trypsin inhibitor solution. Cells were spun down and transferred to DMEM (Invitrogen) with 10% fetal bovine serum (DMEMϩ). Striatal cells were immediately transfected with YFP on a ␤-actin promoter (a gift from A. M. Craig, University of British Columbia), PSD-95-GFP, or palmitoylation-resistant PSD-95 in which the cysteines were mutated to serines (PSD-95(C3S,C5S)-GFP) (23) . For all transfections, 2 million cells were suspended in 100 l of electroporation buffer (Mirus Bio) with 2 g of DNA, placed in a cuvette (Bio-Rad), and electroporated (AMAXA Nucleofector I, program 05). Striatal neurons were then plated with non-transfected cortical neurons at a 1:1 ratio on 12-mm poly-D-lysine-coated coverslips (Marienfeld). Cells were maintained at 37°C and 5% CO 2 . 2-4 h after plating, DMEMϩ was replaced with 500 l of plating medium (Neurobasal medium, B27, glutamine, and penicillin/streptomycin; Invitrogen). An additional 500 l of plating medium was added on days in vitro (DIV) 3-4, and subsequent half-media changes took place every 3-7 days thereafter. For certain experiments, cultures were treated on DIV13-15 prior to fixation. For the BDNF experiments, 5 nM BDNF (Tocris) was added directly to the plating medium for 2 h. TrkB-Fc (0.7 g/ml; R&D Systems) was added to the plating medium for 4 h. For picrotoxin (PTX)/4-aminopyridine (4-AP) experiments, 50 M PTX and 10 M 4-AP were directly added to the plating medium for 4 h.
Immunocytochemistry and Cluster Analysis-On DIV13-15, coverslips were fixed with 4% paraformaldehyde and 4% sucrose for 15-20 min and washed three to five times with PBS. Cells were immediately permeabilized with methanol (5 min at Ϫ20°C) and then subjected to an additional PBS washing and a 5-min incubation in PBS with 0.03% Triton X-100 (PBST). Coverslips were blocked in PBS with 10% normal goat serum (30 min at room temperature) and incubated overnight with primary antibodies. The primary antibody mixture (diluted in PBST with 2% normal goat serum) consisted of chicken anti-GFP (1:1000; Abcam ab13970), mouse anti-PSD-95 (1:1000; Thermo Scientific MA1-045), and guinea pig anti-VGLUT1 (vesicular glutamate transporter 1; 1:4000; Chemicon AB5905). Coverslips were washed four to six times with PBST and then incubated with secondary antibodies for 1.5 h at room temperature. The secondary antibody mixture consisted of Alexa Fluor 488-conjugated goat anti-chicken (1:1000; Invitrogen A11039), Alexa Fluor 568-conjugated goat anti-mouse (1:1000; Invitrogen A11031), and aminomethylcoumarin acetate-conjugated goat anti-guinea pig (1:100; Jackson ImmunoResearch Laboratories 706-155-148). Coverslips were then washed a final three to five times with PBST prior to being slide-mounted with Fluoromount (SouthernBiotech).
Images were acquired with a Zeiss Axiovert 200M fluorescence microscope using ZEN 2012 software. Primary and secondary dendrites were imaged at ϫ63 magnification (oil immersion, 1.4 numerical aperture) by taking 12 optical sections in 0.4-m steps in the z-plane. Of these, three to five images centered on the dendrites were flattened using the extended focus function and exported as raw unprocessed TIFF files. Exposure times were kept constant throughout all experiments. TIFF files were imported into ImageJ, and three regions of interest per cell were drawn around primary or secondary dendrites according to the YFP signal. The regions of interest were then superimposed onto the PSD-95 and VGLUT1 images, and these images were manually thresholded within the regions of interest to eliminate background and to preserve punctate staining. All thresholding was done with treatments/ genotypes interleaved and the experimenter blinded to condition. The binary thresholded images were then analyzed for punctum density, size, and co-localization using the Analyze Particles tool and the co-localization plug-in for ImageJ. Values from all three regions of interest were averaged to generate a mean value for each cell. Multiple conditions (genotype and/or treatment) were simultaneously processed (blind/interleaved), and the resultant data were normalized to the control condition by dividing each value by the mean value of the control group for a given parameter. Reported n indicates the number of cells analyzed from a minimum of three independent cultures.
Subcellular Fractionation-Subcellular fractionation was conducted on tissue from 1-2-month-old mice essentially as described previously (19) . FVB/N and YAC18 tissues were paired on the day of dissection. The striatum was dissected on ice in 0.32 M sucrose buffer (0.32 M sucrose and 10 mM HEPES, pH 7.4) containing phosphatase and protease inhibitor mixtures (Roche Diagnostics) and homogenized in 200 l of 0.32 M sucrose buffer. Fractionation was performed as described (19) to separate the non-PSD and PSD compartments from the P2 crude synaptosomal membranes. Samples were stored at Ϫ80°C until used.
The BCA protein assay was used as described (19) , but 12.5 g of sample was heated to 95°C for 5 min and separated by 10% SDS-PAGE. Blocking was done at room temperature in 3% BSA and 0.5% Tween 20 in TBS (TBST) for 120 min, and the membranes were then incubated overnight in primary antibody diluted in 3% BSA in TBST at 4°C. Secondary antibody incubation and data quantification were performed as described (19) . Primary antibodies used included mouse anti-PSD-95 (UC Davis/National Institutes of Health NeuroMab, 75-028; 1:1000) and goat anti-␤-actin (Santa Cruz Biotechnology, sc-1616; 1:4500). Secondary antibodies used included donkey anti-goat HRP (Santa Cruz Biotechnology, sc-2020; 1:5000) and sheep anti-mouse HRP (GE Healthcare, NA931V; 1:5000). Acyl-Biotinyl Exchange Assay-Striatal tissue was dissected from FVB/N and YAC18 mice and homogenized in lysis buffer (150 mM NaCl, 50 mM Tris, pH 7.4, 5 mM EGTA containing 1 M N-ethylmaleimide, 0.5 mM PMSF, and one tablet of protease inhibitor mixture (leupeptin/chymostatin/pepstatin/aprotinin per 10 ml of buffer; Roche Diagnostics)). Triton X-100 was added at 1.7%, and cells were rotated end-over-end at 4°C for 1 h. Particulates and unbroken cells were removed by centrifugation at 10,000 ϫ g for 10 min at 4°C. The protein extracts were then subjected to chloroform/methanol precipitation as described previously (24) . One-half of the sample was treated with neutral pH 1 M hydroxylamine for 1 h to remove palmitate from Cys residues, whereas the other half served as a negative control. Both samples were then treated with the Cys-crosslinking reagent N-[6(biotinamido)hex1]-3Ј-(2Ј-pyridyldithio)propionamide (HPDP)-biotin (1 mM), which is attached to a biotin moiety. Biotinylated proteins were pulled down with streptavidin-Sepharose beads.
For palmitoylation analysis of PSD-95 in culture, striatal and cortical co-cultures were prepared as described above and plated on a 10-cm culture dish. At DIV14, cultures were treated with 10 M 4-AP and 100 M PTX for 4 h, and neurons were then harvested and processed as described above.
The resultant proteins were resuspended in Laemmli buffer (4% SDS, 20% glycerol, 10 mM DTT, 0.004% bromphenol blue, 0.125 M Tris-HCl, pH 6.8), and samples were analyzed by SDS-PAGE (NuPAGE 4 -12% Bis-Tris gel, Invitrogen). SDS-polyacrylamide gels were transferred onto nitrocellulose membrane (Amersham Biosciences; 0.5 A for 90 min at 4°C) to probe with specific antibodies. Anti-PSD-95 (1:1000) and anti-actin (Sigma; 1:500) primary antibodies were applied overnight in Odyssey blocking buffer (LI-COR Bioscience). IRD800-labeled anti-rabbit (Rockland; 1:10,000) and Alexa Fluor 680-labeled anti-mouse (Invitrogen; 1:10,000) secondary antibodies were used. The immunoblots were scanned using an Odyssey infrared imaging system (LI-COR Bioscience) and quantified with ImageJ.
Whole Cell Electrophysiology-On DIV13-15, coverslips were transferred to a recording chamber perfused with 167 mM NaCl, 2.4 mM KCl, 10 mM glucose, 10 mM HEPES, 2 mM CaCl 2 , 1 mM MgCl 2 , 0.05 mM PTX, and 0.0003 mM tetrodotoxin (TTX), pH 7.3, with NaOH. To record miniature excitatory postsynaptic currents (mEPSCs), pipettes (3-6 megohms (M⍀)) were filled with an internal solution consisting of 145 mM potassium gluconate, 1 mM MgCl 2 , 10 mM HEPES, 1 mM EGTA, 2 mM MgATP, and 0.5 mM Na 2 GTP. For all whole cell experiments, the series resistance obtained was typically 10 -20 M⍀ and was tolerated up to a maximum of 25 M⍀. Cells in which the series resistance changed by Ͼ30% were discarded. To record AMPAR rectification in culture, TTX was removed from the bath solution, and 10 M 4-AP and 50 M D(Ϫ)-2amino-5-phosphonovaleric acid were applied near the coverslip via theta tube to facilitate large burst EPSCs and to block NMDARs, respectively. The internal solution used consisted of 130 mM CsMe, 5 mM CsCl, 4 mM NaCl, 1 mM MgCl 2 , 10 mM HEPES, 5 mM EGTA, 5 mM lidocaine, 0.5 mM NaGTP, 10 mM sodium phosphocreatine, 5 mM MgATP, and 0.1 mM spermine, pH 7.3, at 280 mosM. Burst EPSCs were recorded at a holding potential of Ϫ70 mV and then at ϩ40 mV. The average burst amplitude at ϩ40 mV was divided by the average burst amplitude at Ϫ70 mV to generate an AMPAR rectification index. To quantify synaptic NMDAR content, SPNs were patched with the cesium-based internal solution, and the MgCl 2 concentration in the bath solution was reduced to 10 M. Burst EPSCs mediated by both AMPARs and NMDARs were induced by theta tube application of 10 M 4-AP in the absence of TTX. After 3-5 min of burst EPSCs, 10 M MK-801 was applied via theta tube in addition to 4-AP to block the NMDAR component of the burst EPSCs. Synaptic NMDAR content was quantified as the percentage of burst EPSC area reduced by MK-801.
For recordings in acute slices, mice were anesthetized with halothane, and brains were quickly removed and placed in icecold slicing solution containing 125 mM NaCl, 2.5 mM KCl, 25 mM NaHCO 3 , 1.25 mM NaH 2 PO 4 , 2.5 mM MgCl 2 , 0.5 mM CaCl 2 , and 10 mM glucose. Coronal sections (400 m) containing the striatum were obtained using a Leica VT1200S vibratome and immediately transferred to artificial cerebrospinal fluid warmed to 32-35°C for 30 -45 min. The composition of the artificial cerebrospinal fluid was the same as that of the slicing solution except the concentrations of MgCl 2 and CaCl 2 were 1 and 2 mM, respectively. For recordings, hemisections were transferred to a recording chamber perfused with artificial cerebrospinal fluid that also contained PTX (50 M), glycine (10 M), and strychnine (2 M). Patch pipettes were 3-6 M⍀ when filled with the cesium-based internal solution described above, and cells (ϳ15-m soma diameter) in the dorsomedial striatum, visualized with a differential interference contrast microscope, were targeted. Glutamate afferents were stimulated by positioning an artificial cerebrospinal fluid-filled glass pipette (ϳ1 M⍀) 200 -300 m dorsal to the target cell. EPSCs were evoked by 0.04-ms pulses at a stimulation intensity that generated a half-maximal response (typically, 150 A). NMDAR responses were quantified by subtracting the AMPAR-evoked EPSC at ϩ40 mV (in the presence of 50 M D(Ϫ)-2-amino-5phosphonovaleric acid) from the dual (AMPAR ϩ NMDAR)evoked EPSC at ϩ40 mV prior to D(Ϫ)-2-amino-5-phosphonovaleric acid application. AMPAR responses were recorded at Ϫ70 mV in the presence of D(Ϫ)-2-amino-5-phosphonovaleric acid. Weighted ( w ) was calculated as described (19) . All elec-trophysiological data were analyzed off-line using Clampfit 10.2 software.
RESULTS

Increased Levels of Wild-type HTT Enhance Striatal Neuronal Synaptic Clustering of PSD-95 via a Palmitoylation-dependent Mechanism-
The presence of mHTT can influence the localization of PSD-95, with higher expression being observed in non-synaptic fractions (15) . Here, we sought to determine whether expression levels of wtHTT can influence PSD-95 localization. We performed triple label immunocytochemistry on corticostriatal co-cultures obtained from FVB/N (WT) and wtHTT-overexpressing YAC18 mice ( Fig. 1 ). Striatal neurons were transfected with YFP on the day of plating for identification, and all analyses were obtained from primary and secondary dendrites of SPNs between DIV13 and DIV15. We found a significant enhancement of PSD-95 cluster size (Fig. 1, A and  B) , but not density (Fig. 1E ), in cultured YAC18 SPNs compared with WT SPNs. This was associated with an increase in the co-localization of PSD-95 with the presynaptic marker VGLUT1 (Fig. 1C ), suggesting enhanced PSD-95 clustering at synaptic sites as a result of wtHTT overexpression. In contrast, we saw no evidence for an increase in the size or density of VGLUT1 puncta (Fig. 1, D and F) .
PSD-95 is palmitoylated at two N-terminal cysteine residues, Cys-3 and Cys-5 (25) . The palmitoylation of PSD-95 is a dynamic process controlling its targeting to synaptic sites (23, 26) . To determine whether palmitoylation is involved in the enhanced PSD-95 clustering in YAC18 SPNs, we first quantified PSD-95 palmitoylation in striatal tissue from 1-month-old WT and YAC18 mice. In agreement with the increased synaptic clustering observed in culture, we found that PSD-95 palmitoylation was significantly enriched in YAC18 striatum compared with WT striatum (Fig. 2, A and B) . Consistent with the palmitoylation-dependent synaptic targeting of PSD-95, as well as our data in corticostriatal co-cultures ( Fig. 1) , we also observed a significant increase in the amount of PSD-95 protein in synaptic fractions (Fig. 2D) . This likely represented a redistribution of PSD-95, as total levels were unaffected (Fig. 2C) . In contrast to the striatum, PSD-95 palmitoylation was not different between WT and YAC18 cortical tissues (Fig. 2E) , and we saw no evidence for a change in PSD-95 clustering in YFP-transfected cortical neurons in co-culture with SPNs (Fig. 2F) . Thus, HTT increases both PSD-95 palmitoylation and clustering selectively in striatal neurons. Examples of enlarged puncta are denoted with arrows in A. C, co-localization of PSD-95 with the presynaptic marker VGLUT1 was also enhanced in YAC18 SPNs, suggesting that the enhanced PSD-95 clustering occurs at synaptic sites (WT, n ϭ 20; YAC18, n ϭ 23; ***, p Ͻ 0.001, unpaired t test). D-F, VGLUT1 cluster size (D) was unaffected, as was PSD-95 (E) and VGLUT1 (F) cluster density (p Ͼ 0.05, unpaired t test). Huntingtin Influences PSD-95 Clustering FEBRUARY 7, 2014 • VOLUME 289 • NUMBER 6
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To determine whether the enhanced clustering in YAC18 SPNs was palmitoylation-dependent, we transfected SPNs with GFP-tagged PSD-95 and co-cultured them with non-transfected cortical neurons. As we saw with endogenous PSD-95, exogenous PSD-95-GFP clustered more efficiently in YAC18 SPNs as evidenced by the larger cluster size (Fig. 3, A and B) . When SPNs were transfected with a palmitoylation-resistant PSD-95 construct (PSD-95(C3S,C5S)-GFP), clustering was significantly reduced, and the GFP signal was much more diffuse (Fig. 3, A and B) , consistent with previous results in hippocampal neurons (23) . Importantly, the ability of wtHTT overexpression to increase PSD-95 clustering was lost in the presence of PSD-95(C3S,C5S) ( Fig. 3, A and B) , suggesting that wtHTTinduced PSD-95 clustering is palmitoylation-dependent. Next, we treated cultures with 4-AP (10 M; to block voltage-gated potassium currents and to prolong action potentials) and PTX (50 M; to block inhibition, thereby increasing glutamate release) for 4 h, as it has been shown that prolonged enhancement of hippocampal neuronal activity decreases PSD-95 palmitoylation and clustering (26) . Interestingly, we found that this treatment had no significant effect on PSD-95 palmitoylation in WT co-cultures ( Fig. 3, C and D) , demonstrating that activity-induced reductions in PSD-95 palmitoylation may be region-specific and are not a global phenomenon. Consistent with this, enhancing excitatory synaptic activity in WT co-cultures for 4 h did not influence PSD-95 clustering in SPNs (Fig. 3E ). On the other hand, the same treatment decreased PSD-95 palmitoylation in YAC18 co-cultures ( Fig. 3, C and D) and significantly reduced PSD-95 cluster size measured in YAC18 SPN dendrites back to WT levels (Fig. 3E ).
Together, these results suggest that wtHTT promotes PSD-95 palmitoylation and clustering in SPNs.
Enhanced Synaptic PSD-95 Clustering in Striatal Neurons Is Induced by wtHTT Overexpression in Cortical Neurons and Is
Mimicked and Occluded by Exogenous BDNF-Next, we turned to chimeric cultures to determine whether pre-and/or postsynaptic wtHTT overexpression is required for the observed effect. In these cultures, YAC18 SPNs were co-plated with WT cortical neurons (and vice versa), and immunocytochemical staining and analyses were carried out on SPN dendrites as before. Interestingly, we found that postsynaptic (striatal) overexpression of wtHTT alone was not sufficient to significantly increase PSD-95 cluster size (Fig. 4) . Rather, the presence of YAC18 cortical neurons was sufficient to significantly increase PSD-95 cluster size in WT SPNs by Ͼ50%, a value almost identical to that observed in Fig. 1 when wtHTT was overexpressed in both the pre-and postsynaptic cells.
Previous work in the cortex has demonstrated that BDNF can act postsynaptically on TrkB receptors to increase the palmitoylation and clustering of PSD-95 (27) . Much of the BDNF supply to the striatum originates from the cortex (28), and wtHTT has been shown to facilitate the transcription and trafficking of BDNF (29, 30) . Thus, we hypothesized that increased BDNF release from YAC18 cortex may account for the enhanced PSD-95 clustering in SPNs. To test this possibility, we applied BDNF (5 nM) to the culture medium for 2 h prior to fixation. As shown previously in the cortex (27) , BDNF significantly increased the size of PSD-95 clusters in SPNs from WT co-cultures (Fig. 5, A and C) without a significant effect on cluster density (data not shown). In contrast, BDNF treatment did not induce further enhancement of PSD-95 cluster size in SPNs from YAC18 co-cultures (Fig. 5, A and C) , suggesting occlusion of the effect of BDNF. On the other hand, when a BDNF chelator (TrkB-Fc) was applied in the medium (0.7 g/ml, 4 h), PSD-95 cluster size in YAC18 SPNs was significantly reduced down to WT levels (Fig. 5, B and D) . Together, these results demonstrate that the wtHTT-induced increase in PSD-95 clustering is largely, if not completely, a result of presynaptic wtHTT overexpression. Our results are consistent with a role for BDNF in this effect.
Consequences of wtHTT Overexpression and Enhanced Synaptic PSD-95 Clustering on Corticostriatal Synaptic Transmission-Members of the membrane-associated guanylate kinase family play critical roles in the assembly and stabilization of postsynaptic density. Of this family, PSD-95 appears to be particularly important in the expression of AMPARs at postsynaptic sites. PSD-95 assembles AMPARs at the synapse via interactions between the first two PDZ domains of PSD-95 and the transmembrane AMPAR regulatory protein stargazin (17) . Overexpression of PSD-95 greatly increases AMPAR staining intensity and mEPSC frequency and amplitude in cultured hippocampal neurons (31) . Conversely, acute PSD-95 photoinactivation rapidly disperses AMPARs from hippocampal synapses (32) . To test the hypothesis that wtHTT overexpression also increases AMPAR expression at SPN synapses, we recorded mEPSCs from SPNs in co-culture with cortical neurons at DIV13-15. By this developmental stage, mEPSCs were pronounced, with frequencies and amplitudes over 5 Hz and 20 pA, respectively, commonly observed (Fig. 6, A and D) . To our surprise and in contrast to previous reports in the hippocampus, we saw no evidence for an increase in mEPSC frequency or amplitude in YAC18 SPNs despite the enhanced PSD-95 clustering ( Fig. 6, A-F) . Similarly, when we recorded EPSC bursts in the absence of TTX at Ϫ70 mV and then at ϩ40 mV, WT and YAC18 SPNs displayed near-identical rectification indices ( Fig.   FIGURE 4. Presynaptic mechanisms mediate the effect of wtHTT on PSD-95 clustering. A, representative images of YFP-filled SPN dendrites from WT co-cultures or chimeric cultures consisting of YAC18 SPNs co-cultured with WT cortex (CTX) and vice versa. PSD-95 staining is shown on the right in red. SPN, spiny projection neurons. Scale bar ϭ 5 m. B, PSD-95 cluster size was significantly enhanced in SPNs only when wtHTT was overexpressed in the presynaptic cortical cells (WT/WT, n ϭ 19; 18/WT, n ϭ 28; WT/18, n ϭ 20; **, p Ͻ 0.01, one-way ANOVA with Dunnett's multiple comparison test). n.s., not significant.
FIGURE 5. Effect of wtHTT overexpression on PSD-95 clustering is mimicked by BDNF in WT SPN, and the BDNF effect is occluded in YAC18 SPN.
A and B, representative images of YFP-filled SPN dendrites (green) and PSD-95 staining (red) from WT and YAC18 co-cultures treated with BDNF (A; 5 nM for 2 h directly in the culture medium) or TrkB-Fc (B; 0.7 g/ml for 4 h directly in the culture medium). CTL, control. Scale bar ϭ 5 m. C, BDNF treatment significantly increased PSD-95 cluster size in WT SPNs (control, n ϭ 25; BDNF, n ϭ 24; *, p Ͻ 0.05, unpaired t test) but not in YAC18 SPNs (control, n ϭ 21; BDNF, n ϭ 22; p Ͼ 0.05, unpaired t test). n.s., not significant. D, TrkB-Fc treatment significantly decreased PSD-95 cluster size in YAC18 SPNs (control, n ϭ 21; TrkB-Fc, n ϭ 22; **, p Ͻ 0.01, unpaired t test) but not in WT SPNs (control, n ϭ 22; TrkB-Fc, n ϭ 22; p Ͼ 0.05, unpaired t test). FEBRUARY 7, 2014 • VOLUME 289 • NUMBER 6 JOURNAL OF BIOLOGICAL CHEMISTRY 3523 6 , G and H), suggesting a lack of change in the GluA2 subunit composition of AMPARs.
Huntingtin Influences PSD-95 Clustering
As PSD-95 directly binds NMDARs, we then asked whether PSD-95 draws more NMDARs into the synapse in YAC18 SPNs. Pilot experiments established that isolated NMDAR miniature events are difficult to detect in our co-culture system, both at ϩ40 mV in the presence of magnesium and at Ϫ70 mV in the absence of magnesium. Therefore, in an attempt to quantify synaptic NMDAR current, we calculated the area of EPSC bursts in the absence of TTX before and after MK-801 application. The percent reduction in burst area induced by MK-801 should reflect the relative amounts of NMDARs at the synapse. We found that MK-801 reduced a comparable proportion of EPSC burst area in WT and YAC18 SPNs (Fig. 7, A and B) , suggestive of similar synaptic NMDAR content. To further evaluate synaptic NMDAR properties, we also evoked NMDAR responses in WT and YAC18 acute striatal slices via stimulation of intrastriatal glutamatergic afferents. In agreement with the results in culture, we found no difference in the AMPA/NMDA ratio (Fig. 7, C and D) . Furthermore, NMDAR current decay kinetics were comparable between genotypes (Fig. 7E ). Together, these results demonstrate that despite an enhanced clustering of PSD-95 in YAC18 SPNs in co-culture, there is no detectable change in the amount or subunit composition of either AMPARs or NMDARs under basal conditions. This is in stark contrast to previous reports in the hippocampus (17, 31, 33, 34) .
Knockdown of Endogenous wtHTT Levels Reduces Synaptic PSD-95 Clustering in Striatal Neurons-Numerous HTT-silencing strategies are currently being investigated for their FIGURE 6 . wtHTT overexpression has no effect on mEPSC interevent interval, amplitude, or AMPAR rectification index. A-F, mEPSC recordings from WT and YAC18 SPNs co-cultured with cortical neurons. Representative traces are shown in A and D. There was no effect of genotype on the cumulative distribution of mEPSC interevent interval (B; WT, n ϭ 16; YAC18, n ϭ 17; p Ͼ 0.05, repeated measures two-way ANOVA interaction and genotype) or amplitude (E; WT, n ϭ 16; YAC18, n ϭ 17; p Ͼ 0.05, repeated measures two-way ANOVA interaction and genotype). Mean interevent intervals (IEI; C; WT, n ϭ 16; YAC18, n ϭ 17; p Ͼ 0.05, unpaired t test) and amplitudes (F; WT, n ϭ 16; YAC18, n ϭ 17; p Ͼ 0.05, unpaired t test) were also similar between genotypes. n.s., not significant. G, isolated AMPAR-mediated responses in the absence of TTX and the presence of PTX (50 M) and 4-AP (10 M) resulted in frequently observed burst EPSCs Ͼ100 pA. The average burst EPSC size was determined at a holding potential of Ϫ70 mV and then again at ϩ40 mV to quantify an AMPAR rectification index. H, there was no difference in the AMPAR rectification index between WT and YAC18 SPNs (WT, n ϭ 7; YAC18, n ϭ 7; p Ͼ 0.05, unpaired t test). potential use in the clinic for the treatment of HD. At least some of these approaches lack specificity for mHTT over wtHTT, thereby resulting in lower levels of the wtHTT protein as well as the mHTT protein. Moreover, even if specific mHTT knockdown is achieved, the patient will be left with 50% of total HTT levels. This is a major concern, and little is known about how synaptic function is affected by HTT knockdown. Our above results indicate that overexpression of wtHTT increases PSD-95 palmitoylation and clustering at SPN synapses; therefore, it was of interest to determine whether the opposite is true of wtHTT knockdown. To decrease wtHTT levels, cultures were treated with a pan-specific HTT antisense oligonucleotide (ASO; ISIS Pharmaceuticals, 444664; control ASO, 456838; 500 nM) starting on DIV3-4. HTT knockdown was confirmed by Western blot analysis (Fig. 8A) as described (35) . We found that wtHTT knockdown in corticostriatal co-cultures from WT FVB/N mice resulted in an ϳ25% decrease in PSD-95 cluster size ( Fig. 8B ), suggesting a bidirectional effect of wtHTT levels on PSD-95 clustering. There were no effects of wtHTT knockdown on PSD-95 cluster density (one-way analysis of variance (ANOVA), p ϭ 0.29) or VGLUT1 cluster size (one-way ANOVA, p ϭ 0.43) or density (one-way ANOVA, p ϭ 0.60). We also did not see a reduction in the PSD-95 and VGLUT1 co-localization (one-way ANOVA, p ϭ 0.75), suggesting that synapses are not lost and that the PSD-95 clustering at individual synapses is reduced. SPNs. B, synaptic NMDAR content was quantified by analyzing the percent reduction in the total area of burst EPSCs induced by MK-801. There was no difference between genotypes (WT, n ϭ 4; YAC18, n ϭ 5; p Ͼ 0.05, unpaired t test). C and D, we also found no difference in the AMPA/NMDA ratio using acute coronal slices from WT and YAC18 mice (WT, n ϭ 5; YAC18, n ϭ 7; p Ͼ 0.05, unpaired t test). E, NMDAR decay kinetics were also unaltered by wtHTT overexpression (WT, n ϭ 5; YAC18, n ϭ 7; p Ͼ 0.05, unpaired t test). Tau w , weighted . As we were surprised to see a lack of basal alterations in electrophysiological measures of AMPAR content at YAC18 SPN synapses following wtHTT overexpression, we asked whether the decreased PSD-95 clustering results in a decrease in synaptic AMPAR content. Again, we found no change in the frequency (interevent interval) or amplitude of mEPSCs recorded from WT SPNs in co-culture following ASO treatments (Fig. 8, C and D) , further demonstrating the lack of correlation between PSD-95 and AMPAR content at SPN synapses.
DISCUSSION
Due to the increased implementation of research strategies knocking down HTT for the treatment of HD, there exists a major requirement for the proper assessment of wtHTT function. Although it is accepted that this protein is absolutely essential for development (2) (3) (4) , recent work suggests that partial HTT knockdown in adulthood is well tolerated for up to 6 months (36, 37) . While lacking a complete long-term investigation of the effects of HTT knockdown, those studies do suggest that the treatment of HD may not necessarily require specific knockdown of mHTT. On the other hand, as we have seen with HD, what begins as small alterations in synaptic function (1) can give rise to subsequent cell death and a devastating behavioral, cognitive, and psychiatric phenotype in a relatively short period of time. Here, we began an investigation into the effects of wtHTT on synaptic function by focusing on the most abundant component of the excitatory synapse postsynaptic density, PSD-95. We have show, that wtHTT exerts bidirectional control over the amount of PSD-95 clustering at postsynaptic sites in the striatum. The enhanced clustering was due to PSD-95 palmitoylation and was consistent with the facilitatory role of wtHTT in BDNF transcription and transport from cortical to striatal neurons (29, 30) . We have also shown that knocking down wtHTT is sufficient to decrease PSD-95 clustering.
The effect of wtHTT on PSD-95 was indirect in that wtHTT overexpression was required in the presynaptic cortical neurons rather than the postsynaptic striatal neurons. This came as a surprise, as wtHTT interacts directly with PSD-95 and also increases the enzymatic activity of HIP14 (huntingtin-interacting protein 14) (38) , an important palmitoyl acyltransferase that can palmitoylate PSD-95 (39, 40) . However, the presently observed effect was clearly driven by wtHTT overexpression in cortical neurons, suggesting that wtHTT overexpression induces the release of a signal that acts postsynaptically to enhance PSD-95 clustering. Our data suggest that this factor is BDNF, as the ability for BDNF treatment to increase PSD-95 cluster size was occluded in YAC18 cultures, and the enhanced cluster size in YAC18 cultures was reduced to WT levels by the BDNF scavenger TrkB-Fc. It is known that wtHTT enhances the transcription and trafficking of BDNF from cortical to striatal neurons (29, 30) . Moreover, previous studies indicate that BDNF increases the forward trafficking, palmitoylation, and synaptic incorporation of PSD-95 via postsynaptic TrkB receptor activation (27, 41) : the authors found that BDNF-induced PSD-95 palmitoylation required the activation of signaling pathways downstream of TrkB activation, culminating in a PKM-dependent phosphorylation of the palmitoyl acyltrans-ferase DHHC8. Although we did not investigate the contribution of PKM or DHHC8 in the presently observed effect, our data are consistent with a role for presynaptic BDNF release in the postsynaptic clustering of PSD-95.
Despite the reliance of wtHTT overexpression in the cortex, the enhanced PSD-95 palmitoylation and clustering were observed only in the striatum and not in the cortex itself. This suggests that SPNs and cortical neurons may differ in their response to BDNF and/or additional factors released from the wtHTT-overexpressing cortical neurons. If BDNF is the sole transmitter involved in this effect, then it is surprising that we did not see enhanced PSD-95 palmitoylation and clustering in cortical neurons, as BDNF is known to exert this effect on cultured cortical neurons (27, 41) . Although it is possible that additional factors are released from cortical neurons that act specifically on SPNs to induce the effect, we were able to completely restore clustering to WT levels with a BDNF scavenger, suggesting a major role of BDNF itself. Another possibility is that the amount of BDNF released under basal conditions is greater at corticostriatal synapses compared with corticocortical synapses. BDNF is released in an activity-dependent manner, and in our co-culture system, we observed much greater basal EPSC frequencies when recording from striatal neurons than from cortical neurons, 4 suggesting more activity at the corticostriatal synapse than at the corticocortical synapse in co-cultures. Thus, although exogenous BDNF application to WT cortical neurons may be sufficient to enhance PSD-95 clustering, the basal amount of BDNF released in YAC18 cultures at corticocortical synapses appears insufficient to mimic this effect. A third possibility is that SPNs are highly sensitive to the effects of BDNF. The striatum is reliant upon cortical BDNF release for proper development (28) and is also the area most vulnerable to the effects of brain-wide BDNF deprivation (42) . Furthermore, exogenous BDNF accelerates the growth of cultured striatal but not hippocampal neurons (42) . Although the precise reason for the presently observed specificity remains unclear, our data show that HTT overexpression in cortical neurons results in a specific BDNF-dependent increase in PSD-95 clustering in postsynaptic SPNs and are consistent with a prominent role of BDNF signaling in the striatum.
Perhaps most surprising was the observation that altered PSD-95 clustering did not appear to basally alter the quantity or apparent subunit composition of synaptic AMPARs and NMDARs. This is in stark contrast to previous reports in the hippocampus (17, 31, 33, 34) . Our results suggest that in the striatum, PSD-95 is not a critical determinant of synaptic AMPAR content. Indeed, work in the cortex also suggests that PSD-95 overexpression does not pull AMPARs into the synapse as is seen in the hippocampus (43, 44) , suggesting that regional differences are at play. Nevertheless, cortical PSD-95 was found to be essential to activity-dependent homeostatic synaptic scaling (43) , suggesting that enhanced PSD-95 clustering may influence activity-dependent plasticity in YAC18 SPNs. Even in the hippocampus, the enhanced synaptic AMPAR content following PSD-95 overexpression appears to be activity-dependent (45) , and PSD-95 interactions with AKAP150 (A kinase-anchoring protein 150) are essential to NMDAR-dependent longterm depression (46) . Our data further support the idea that PSD-95 alone cannot account for alterations in basal synaptic AMPAR or NMDAR content. The consequences of PSD-95 clustering on synaptic transmission and activity-dependent plasticity in the striatum remain to be fully elucidated and are of interest for future studies.
Notably, we have shown that wtHTT knockdown results in a decrease in PSD-95 cluster size. Although we did not further examine the mechanism underlying the reduction, it is tempting to suggest that this may be due to PSD-95 depalmitoylation. However, it should be pointed out that scavenging BDNF with TrkB-Fc in WT cultures did not mimic the effect of wtHTT knockdown. Although this may be due to the relative short treatment of TrkB-Fc (4 h) compared with ASO treatment (ϳ10 days), it is possible that the declustering effect is dependent upon an entirely separate mechanism. Our ASO treatments were applied directly to the culture medium and thus would be expected to decrease both pre-and postsynaptic levels of wtHTT. As stated, wtHTT interacts directly with PSD-95 (14) and enhances the enzymatic activity of a palmitoylation enzyme that palmitoylates PSD-95 (38) , suggesting that the declustering effect may be postsynaptically driven. Importantly, our data demonstrate that decreasing wtHTT levels can influence neuronal architecture at the synaptic level. This has important therapeutic implications for nonspecific HTT-reducing strategies for the treatment of HD and highlights the necessity for additional studies on the precise cellular/synaptic effects of wtHTT knockdown.
